Evidence map›Paper›PMID 19543577›Full record

ReviewCanadian journal of gastroenterology = Journal canadien de gastroenterologie2009

Abnormal hematological indices in cirrhosis.

A A Qamar, N D Grace

2 registry-linked trialsOpen access · goldAbstract readReview
In one paragraph

Review in Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03283176 completednot on this mapstarted 2018, after this paper: background citation

Changes in Hematologic Profile, Vitamin B12 and Folic Acid Level in Cirrhotic Patients Received Sofosbuvir and Daclatasvir With or Without Ribavirin

TypeobservationalSponsorAssiut UniversityRan2018 to 2020Enrolled50ConditionsLiver Cirrhoses, Chronic Hepatitis c, Directly Acting AntiviralsArmsVitamin B12 and Folic Acid
NCT07791940 phase4completednot on this mapstarted 2015, after this paper: background citation

Evaluation of the Role of Rifaximin on Thrombocytopenia in Patients With Hepatitis C-Related Liver Cirrhosis

TypeinterventionalSponsorFayoum University HospitalRan2015 to 2016Enrolled165ConditionsThrombocytopenia Related to Chronic Liver DiseaseArmsRifaximin (drug), Rifaximin Placebo
3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 87 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Cytopenias in Autoimmune Liver Diseases-A Review.Journal of clinical medicine · 2025
    Review
  10. How Do Polymorphonuclear Counts in Ascitic Fluid Correlate to Hospital Outcome.Journal of community hospital internal medicine perspectives · 2025
    Article
  11. Article
  12. Hematological abnormalities in liver cirrhosis.World journal of hepatology · 2024
    Review
  13. Review
  14. Article
  15. Article
  16. Real-world Data of Leukopenia Evaluation as Seen in a Community Academic Center.Journal of community hospital internal medicine perspectives · 2023
    Article
  17. Fibrin clot properties and thrombus composition in cirrhosis.Research and practice in thrombosis and haemostasis · 2023
    Article
  18. Article
  19. Liver cirrhosis and immune dysfunction.International immunology · 2022
    Review
  20. An Unusual Case of Hemolytic Anemia Reversed with Liver Transplantation.International journal of hematology-oncology and stem cell research · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

A A QamarBrigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. aqamar@partners.org
N D Grace
Brigham and Women's Hospital · USHarvard University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Abnormalities in hematological indices are frequently encountered in cirrhosis. Multiple causes contribute to the occurrence of hematological abnormalities. Recent studies suggest that the presence of hematological cytopenias is associated with a poor prognosis in cirrhosis. The present article reviews the pathogenesis, incidence, prevalence, clinical significance and treatment of abnormal hematological indices in cirrhosis.

Indexed as

Hematologic DiseasesHematopoietic Cell Growth FactorsHumansHypertension, PortalLiver CirrhosisHematopoietic Cell Growth Factors

Identifiers

PMID19543577
PMCPMC2721814
OpenAlexW143861169

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.